IL-12 protects from psoriasiform skin inflammation - Kulig, Paulina; Musiol, Stephanie; Freiberger, Sandra Nicole; Schreiner, Bettina; Gyülveszi, Gabor; Russo, Giancarlo; Pantelyushin, Stanislav; Kishihara, Kenji; Alessandrini, Francesca; Kündig, Thomas; Sallusto, Federica; Hofbauer, Günther F.L.; et al. (Nature communications, 2016)
Keywords: 13/21; 14; 38/39; 631/250/127/1213; 64/60; 692/699/249/2510/1758; 82/29; 82/51; 9/10; 96/31; Aminoquinolines - pharmacology; Aminoquinolines - therapeutic use; Animals; Cytokines; Dendritic cells; Female; Humanities and Social Sciences; Humans; Immunology; Inflammation - complications; Inflammation - drug therapy; Inflammation - pathology; Inflammation - prevention & control; Interleukin-12 - metabolism; Interleukin-23 - metabolism; Keratinocytes - drug effects; Keratinocytes - metabolism; Keratinocytes - pathology; Lymphocytes; Mice, Inbred C57BL; Monoclonal antibodies; multidisciplinary; Neutralization; Pathogenesis; Psoriasis; Psoriasis - complications; Psoriasis - drug therapy; Psoriasis - pathology; Psoriasis - prevention & control; Receptors, Antigen, T-Cell, gamma-delta - metabolism; Science; Science (multidisciplinary); Skin - drug effects; Skin - pathology; Skin diseases; Switzerland